Kathryn Hatchell

13PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersCancer geneticsGene expression (incl. microarray and other genome-wide approaches)Haematological tumoursEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 22, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients.

Neal D Shore, Christopher M Pieczonka, Sean Heron

|Aug 03, 2023
Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer.

Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen

|Dec 11, 2022
Ashkenazi Jewish and Other White APC I1307K Carriers Are at Higher Risk for Multiple Cancers.

Esther Forkosh, Michael Bergel, Kathryn E Hatchell

|Nov 12, 2022
Multigene Panel Testing Yields High Rates of Clinically Actionable Variants Among Patients With Colorectal Cancer.

Sarah E Coughlin, Brandie Heald, Dana Farengo Clark

|Mar 01, 2022
Germline alterations among Hispanic men with prostate cancer.

Elizabeth Pan, Justin Shaya, Lisa Madlensky

Pageof 3